Background: Irrational drug prescribing is associated with increased morbidity, mortality and economic burden on the society. Study of prescribing pattern is a component of medical audit that does monitoring and evaluation of the prescribing practice of the prescribers and recommends necessary modifications to achieve rational medical care. 
Introduction
Diabetes mellitus is a metabolic disorder with common denominator of hyperglycemia, arising from a variety of pathogenic mechanisms. It has emerged as an epidemic both in the developing and developed countries and shows no signs of regression. [1] Currently, India leads the world with the largest number of diabetic subjects and this is expected to further rise in the coming years.
Given the high prevalence of diabetes in Indians with over 50 million diabetics already, and the numbers expected to increase to 87 million by the year 2030, this could place considerable burden on the health budgets of this country. [2] The study of prescribing pattern is a component of medical audit that does monitoring and evaluation of the prescribing practice of the prescribers as well as recommends necessary modifications to achieve rational and cost effective medical care. [3] Therefore, drug utilization studies, which evaluate and analyse the medical, social and economic outcomes of the drug therapy, are more meaningful, and observe the prescribing attitude of physicians with the aim to provide drugs rationally. [4, 5] Keeping all these facts in consideration, the present study was designed to analyze the prescribing patterns of antidiabetic drugs in a tertiary care teaching hospital in Dehradun, Uttarakhand. 
Materials and Methods

Discussion
A prescription based survey is considered to be one of the most effective methods to assess and evaluate the prescribing attitude of the physicians and dispensing practice of the pharmacists. [7] In the present study, the incidence of diabetes was seen in 159 (50.96%) male and 153 (49.04%) female patients. This was comparable with previous study by Guercil et al where men and women were 53.7% and 46.3% respectively. [8] The mean age of the patients in the present study was 54.96 ± 0.57 years which was lower than previous studies where mean age was 60.9 ± 9.4 years and 58. As our hospital is a charitable institution and the area nearby is inhabited by people belonging to upper middle and lower middle class, the majority of patients of these particular class approach this hospital, thereby changing our findings.
Amongst antidiabetic medications, metformin was the most commonly prescribed drug which was given in 273 (40.99%) patients followed by glimepride in 228 (34.23%) -45 (6.76%) had pioglitazone and other drugs. Similar prescribing trend was observed in another study by Vengurlekar S et al where metformin was most commonly prescribed (27%) followed by glimepride (22.60%) and pioglitazone (13.9%). Another study by Dhanaraja et al also shows metformin is the most commonly prescribed oral antidiabetic drug. [14, 15] Metformin does not promote weight gain and has beneficial effects on several cardiovascular risk factors. Accordingly, metformin is reported to be regarded as the first drug of choice for most patients with type 2 diabetes mellitus. [16] Our study supported the same conclusion.
A total of 246 (36.93%) fixed dose combinations were prescribed which was consistent with another study by Kumar M A, where 41.1% fixed drug combinations were used. [17] Most common was a combination of metformin and glimepride (183, 74.4%). Vengurlekar et al also showed similar results, which showed a combination of metformin and glimepride as most widely prescribed fixed dose combination. [14] Oral antidiabetics drugs were prescribed in majority of patients (99.03%), which corresponds with the study by Vengurlekar et al, where 95% oral antidiabetics were prescribed. [14] The total number of drugs prescribed per prescription was 3.98, which was less as compared to the study by 
LIMITATIONS
Sample size in the present study was small and we might have focused only on the first prescription, this necessarily does not reflect the true clinical situation. We did not record the dose and dosing schedule of the treatment given. We also did not evaluate factors like treatment adherence, concerns of the patients about side effects, and adherence to treatment guidelines while prescribing.
Conclusion
To conclude, most of the prescriptions were rational, but further improvement is needed. Further studies focussed on rationale for choice of drug based on demographic data, economic status, associated conditions and complications would give additional insights into prescribing patterns in diabetes mellitus in India duration as well as interaction with other medications. A therapeutic audit with more parameters of analysis to provide regular feedback to researchers and prescribers may encourage rational prescribing in hypertension.
